MedPath

Klinfar

Brand Name: Klinfar

Generic Name: Clindamycin (as phosphate)

Active
Registration Number

DRP-15462

Dosage Form

Solution for Injection (IM/IV)

Issuance Date

August 1, 2024

Expiry Date

August 1, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength150 mg/mL (300 mg/2mL)
PackagingUSP Type I clear glass ampoule x 2 mL (Box of 1's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Antibacterial (Lincosamide)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Clindamycin (as phosphate)Active
Monograph: Clindamycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform